Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phagocytes | 8 | 2007 | 294 | 0.740 |
Why?
|
| Sister Chromatid Exchange | 11 | 1990 | 60 | 0.740 |
Why?
|
| Medical Receptionists | 1 | 2017 | 2 | 0.580 |
Why?
|
| DNA Damage | 8 | 2007 | 2461 | 0.440 |
Why?
|
| Nitrosamines | 3 | 1999 | 88 | 0.410 |
Why?
|
| Anticarcinogenic Agents | 2 | 2007 | 251 | 0.400 |
Why?
|
| Medical Records | 1 | 2017 | 1413 | 0.380 |
Why?
|
| Antioxidants | 6 | 2007 | 1678 | 0.320 |
Why?
|
| Organoplatinum Compounds | 1 | 2010 | 408 | 0.300 |
Why?
|
| beta-Glucans | 1 | 2008 | 129 | 0.290 |
Why?
|
| Lovastatin | 1 | 2007 | 115 | 0.290 |
Why?
|
| Plants, Toxic | 2 | 1999 | 70 | 0.270 |
Why?
|
| Oxygen | 10 | 1990 | 4269 | 0.270 |
Why?
|
| Free Radicals | 13 | 1999 | 238 | 0.270 |
Why?
|
| Magnesium | 1 | 2010 | 816 | 0.260 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 16 | 2008 | 11843 | 0.260 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2010 | 303 | 0.260 |
Why?
|
| Carcinogens | 2 | 1997 | 455 | 0.210 |
Why?
|
| Vitamin E | 5 | 1997 | 873 | 0.190 |
Why?
|
| Purpura | 1 | 2001 | 117 | 0.180 |
Why?
|
| Catechin | 1 | 1999 | 70 | 0.160 |
Why?
|
| Niacin | 2 | 1990 | 117 | 0.160 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 2 | 1990 | 225 | 0.160 |
Why?
|
| Diterpenes | 1 | 1999 | 170 | 0.160 |
Why?
|
| Leukotrienes | 2 | 1990 | 230 | 0.150 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1998 | 106 | 0.150 |
Why?
|
| Tea | 1 | 1999 | 290 | 0.150 |
Why?
|
| Arachidonic Acids | 2 | 1988 | 296 | 0.150 |
Why?
|
| Blood Component Transfusion | 1 | 1998 | 142 | 0.140 |
Why?
|
| Lymphocytes | 3 | 1990 | 2611 | 0.140 |
Why?
|
| beta Carotene | 2 | 1997 | 523 | 0.140 |
Why?
|
| Cricetinae | 11 | 1990 | 2423 | 0.140 |
Why?
|
| Calcium | 1 | 2010 | 5793 | 0.140 |
Why?
|
| Neoplasms | 11 | 2008 | 22386 | 0.140 |
Why?
|
| DNA | 4 | 1999 | 7213 | 0.130 |
Why?
|
| Colorectal Neoplasms | 5 | 2010 | 6978 | 0.130 |
Why?
|
| Reactive Oxygen Species | 3 | 2007 | 2150 | 0.120 |
Why?
|
| Pulmonary Edema | 1 | 1998 | 409 | 0.120 |
Why?
|
| Lipid Peroxides | 3 | 1990 | 74 | 0.120 |
Why?
|
| Superoxides | 3 | 1999 | 389 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1998 | 679 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2001 | 5426 | 0.110 |
Why?
|
| Neutropenia | 2 | 1992 | 892 | 0.110 |
Why?
|
| Etoposide | 5 | 2001 | 640 | 0.110 |
Why?
|
| Ascorbic Acid | 2 | 1987 | 658 | 0.100 |
Why?
|
| Idarubicin | 2 | 1992 | 59 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3253 | 0.100 |
Why?
|
| Daunorubicin | 2 | 1992 | 157 | 0.100 |
Why?
|
| Ataxia Telangiectasia | 1 | 1993 | 107 | 0.100 |
Why?
|
| Mutagens | 1 | 1993 | 181 | 0.100 |
Why?
|
| Deferoxamine | 3 | 1990 | 155 | 0.100 |
Why?
|
| Stem Cells | 1 | 2005 | 3538 | 0.100 |
Why?
|
| Doxorubicin | 1 | 1998 | 2229 | 0.090 |
Why?
|
| Catalase | 5 | 1990 | 219 | 0.090 |
Why?
|
| Adenosine Deaminase Inhibitors | 1 | 1990 | 9 | 0.090 |
Why?
|
| Pentostatin | 1 | 1990 | 26 | 0.090 |
Why?
|
| Cytarabine | 2 | 1992 | 697 | 0.090 |
Why?
|
| Nucleoside Deaminases | 1 | 1990 | 58 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 1999 | 826 | 0.090 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 1996 | 555 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1990 | 247 | 0.080 |
Why?
|
| Radiation, Nonionizing | 1 | 1989 | 5 | 0.080 |
Why?
|
| Fluorouracil | 8 | 1996 | 1656 | 0.080 |
Why?
|
| Lung Neoplasms | 6 | 2001 | 13589 | 0.080 |
Why?
|
| Fibroblasts | 5 | 1997 | 4180 | 0.080 |
Why?
|
| Cisplatin | 6 | 2001 | 1661 | 0.080 |
Why?
|
| Research Design | 1 | 2005 | 6217 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1990 | 344 | 0.080 |
Why?
|
| Superoxide Dismutase | 5 | 1990 | 596 | 0.080 |
Why?
|
| Chloramines | 1 | 1987 | 15 | 0.070 |
Why?
|
| Glutathione | 2 | 1987 | 587 | 0.070 |
Why?
|
| DNA, Single-Stranded | 3 | 1997 | 354 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13708 | 0.070 |
Why?
|
| Lymphatic Diseases | 2 | 1986 | 320 | 0.070 |
Why?
|
| Autoimmune Diseases | 2 | 1992 | 2260 | 0.070 |
Why?
|
| Thrombocytopenia | 5 | 1998 | 1183 | 0.070 |
Why?
|
| Cells, Cultured | 8 | 1999 | 19041 | 0.060 |
Why?
|
| Leukemoid Reaction | 1 | 1985 | 18 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 1989 | 865 | 0.060 |
Why?
|
| Platelet Aggregation | 1 | 1989 | 772 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2008 | 807 | 0.060 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 1985 | 72 | 0.060 |
Why?
|
| Humans | 61 | 2017 | 768451 | 0.060 |
Why?
|
| Carcinoid Tumor | 1 | 1986 | 226 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3484 | 0.060 |
Why?
|
| Guided Tissue Regeneration | 1 | 2005 | 88 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 1990 | 1395 | 0.060 |
Why?
|
| Lung | 3 | 1999 | 10090 | 0.060 |
Why?
|
| Agranulocytosis | 1 | 1984 | 98 | 0.060 |
Why?
|
| Adenine | 1 | 1990 | 993 | 0.060 |
Why?
|
| Cricetulus | 4 | 1989 | 815 | 0.060 |
Why?
|
| Hydrogen Peroxide | 3 | 1999 | 742 | 0.060 |
Why?
|
| Zidovudine | 3 | 1996 | 625 | 0.060 |
Why?
|
| Adenoma, Islet Cell | 1 | 1983 | 72 | 0.050 |
Why?
|
| Heparin | 2 | 1982 | 1636 | 0.050 |
Why?
|
| Adenocarcinoma | 4 | 2001 | 6400 | 0.050 |
Why?
|
| Reticulocytes | 1 | 1984 | 289 | 0.050 |
Why?
|
| Mediastinal Neoplasms | 1 | 1986 | 403 | 0.050 |
Why?
|
| Neural Tube Defects | 1 | 1985 | 255 | 0.050 |
Why?
|
| Asbestos | 1 | 1985 | 251 | 0.050 |
Why?
|
| Crossing Over, Genetic | 1 | 1983 | 92 | 0.050 |
Why?
|
| Leukemia, Hairy Cell | 1 | 1983 | 82 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1990 | 2847 | 0.050 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 1984 | 147 | 0.050 |
Why?
|
| Drug Evaluation | 6 | 1990 | 642 | 0.050 |
Why?
|
| Rhode Island | 4 | 1988 | 353 | 0.050 |
Why?
|
| Cell Line | 7 | 1990 | 15609 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2017 | 4340 | 0.050 |
Why?
|
| Xanthine Oxidase | 3 | 1987 | 69 | 0.050 |
Why?
|
| Mass Screening | 2 | 1988 | 5455 | 0.050 |
Why?
|
| Hepatitis B virus | 1 | 1985 | 530 | 0.050 |
Why?
|
| Neutrophils | 2 | 1992 | 3790 | 0.050 |
Why?
|
| Orbital Neoplasms | 1 | 1983 | 223 | 0.050 |
Why?
|
| Combined Modality Therapy | 8 | 2001 | 8559 | 0.040 |
Why?
|
| Ovary | 4 | 1987 | 960 | 0.040 |
Why?
|
| Diagnosis | 1 | 1981 | 156 | 0.040 |
Why?
|
| Enterococcus faecalis | 1 | 1981 | 245 | 0.040 |
Why?
|
| Thiazoles | 1 | 1987 | 1541 | 0.040 |
Why?
|
| Egtazic Acid | 2 | 1990 | 166 | 0.040 |
Why?
|
| Meningitis | 1 | 1981 | 219 | 0.040 |
Why?
|
| Lymphoma | 1 | 2008 | 1907 | 0.040 |
Why?
|
| Medical Audit | 1 | 1980 | 454 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1980 | 187 | 0.040 |
Why?
|
| Platelet Count | 1 | 1982 | 786 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2008 | 2058 | 0.040 |
Why?
|
| Toxoplasmosis | 1 | 1979 | 94 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1992 | 3623 | 0.040 |
Why?
|
| Leucovorin | 3 | 1996 | 643 | 0.040 |
Why?
|
| Adult | 20 | 2008 | 223542 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 1992 | 2969 | 0.040 |
Why?
|
| Radiotherapy Dosage | 2 | 2001 | 2925 | 0.040 |
Why?
|
| Female | 32 | 2008 | 396943 | 0.040 |
Why?
|
| Colonic Neoplasms | 3 | 1988 | 2544 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1986 | 2203 | 0.040 |
Why?
|
| Hepatitis | 1 | 1979 | 228 | 0.040 |
Why?
|
| Mannitol | 2 | 1990 | 177 | 0.040 |
Why?
|
| Drug Synergism | 2 | 1993 | 1765 | 0.040 |
Why?
|
| Aged | 23 | 2008 | 171520 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 1644 | 0.030 |
Why?
|
| Leukocyte Count | 3 | 1992 | 1604 | 0.030 |
Why?
|
| Computers | 1 | 1979 | 592 | 0.030 |
Why?
|
| Oxidation-Reduction | 4 | 1987 | 2232 | 0.030 |
Why?
|
| Hodgkin Disease | 1 | 1984 | 1386 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 1985 | 1898 | 0.030 |
Why?
|
| Male | 29 | 2008 | 364781 | 0.030 |
Why?
|
| Adenosine Diphosphate | 2 | 1989 | 423 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 1980 | 603 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 1980 | 1158 | 0.030 |
Why?
|
| Middle Aged | 23 | 2008 | 223418 | 0.030 |
Why?
|
| Medical History Taking | 1 | 1979 | 776 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 1981 | 539 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1980 | 749 | 0.030 |
Why?
|
| Phenotype | 1 | 1993 | 16712 | 0.030 |
Why?
|
| Neoplasm Staging | 4 | 2001 | 11249 | 0.030 |
Why?
|
| Electromagnetic Fields | 1 | 1996 | 290 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 1985 | 3212 | 0.030 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1993 | 110 | 0.030 |
Why?
|
| Remission Induction | 4 | 1992 | 2408 | 0.030 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1992 | 87 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 1993 | 212 | 0.020 |
Why?
|
| Animals | 16 | 1996 | 169418 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1982 | 2485 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 6856 | 0.020 |
Why?
|
| Clinical Trials as Topic | 3 | 2005 | 8051 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1981 | 1926 | 0.020 |
Why?
|
| Leukocytosis | 1 | 1992 | 251 | 0.020 |
Why?
|
| Mouth Neoplasms | 2 | 1986 | 598 | 0.020 |
Why?
|
| Cyclophosphamide | 2 | 1988 | 2224 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2001 | 4083 | 0.020 |
Why?
|
| Photofluorography | 1 | 1989 | 4 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1993 | 916 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1992 | 621 | 0.020 |
Why?
|
| Cytochrome c Group | 1 | 1989 | 123 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2010 | 65409 | 0.020 |
Why?
|
| Injections, Subcutaneous | 2 | 1982 | 681 | 0.020 |
Why?
|
| Ristocetin | 1 | 1989 | 26 | 0.020 |
Why?
|
| Piroxicam | 1 | 1988 | 18 | 0.020 |
Why?
|
| Rectal Neoplasms | 2 | 1988 | 1179 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1988 | 72 | 0.020 |
Why?
|
| Survival Rate | 2 | 2001 | 12875 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 1990 | 276 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1990 | 868 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1981 | 3458 | 0.020 |
Why?
|
| Methylthioinosine | 1 | 1988 | 4 | 0.020 |
Why?
|
| Vindesine | 1 | 1988 | 12 | 0.020 |
Why?
|
| Karyotyping | 1 | 1990 | 1173 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 1999 | 3145 | 0.020 |
Why?
|
| Indomethacin | 1 | 1988 | 323 | 0.020 |
Why?
|
| Nicotine | 1 | 1993 | 681 | 0.020 |
Why?
|
| Thiazolidines | 1 | 1987 | 70 | 0.020 |
Why?
|
| Students, Medical | 1 | 1981 | 1962 | 0.020 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 1987 | 66 | 0.020 |
Why?
|
| Inosine | 1 | 1988 | 129 | 0.020 |
Why?
|
| Cocarcinogenesis | 1 | 1986 | 49 | 0.020 |
Why?
|
| Aged, 80 and over | 6 | 2008 | 59680 | 0.020 |
Why?
|
| Time Factors | 3 | 2001 | 40271 | 0.020 |
Why?
|
| Pneumonia | 1 | 1978 | 2162 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1987 | 429 | 0.020 |
Why?
|
| Hypoxanthines | 1 | 1985 | 35 | 0.020 |
Why?
|
| Hypoxanthine | 1 | 1985 | 28 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2001 | 39430 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2001 | 4538 | 0.020 |
Why?
|
| Selenious Acid | 1 | 1985 | 6 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1993 | 1539 | 0.020 |
Why?
|
| Benzoic Acid | 1 | 1985 | 16 | 0.020 |
Why?
|
| Infusions, Intravenous | 4 | 1992 | 2228 | 0.020 |
Why?
|
| Fetus | 1 | 1993 | 1883 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1992 | 10784 | 0.020 |
Why?
|
| NAD | 1 | 1989 | 618 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 1983 | 5442 | 0.020 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1985 | 90 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 1998 | 4362 | 0.020 |
Why?
|
| Methionine | 1 | 1987 | 574 | 0.010 |
Why?
|
| Procarbazine | 1 | 1984 | 172 | 0.010 |
Why?
|
| Mechlorethamine | 1 | 1984 | 129 | 0.010 |
Why?
|
| Hepatitis B Vaccines | 1 | 1985 | 177 | 0.010 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1985 | 294 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1984 | 157 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1985 | 262 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1990 | 2604 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 1986 | 437 | 0.010 |
Why?
|
| Benzoates | 1 | 1985 | 213 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1993 | 13026 | 0.010 |
Why?
|
| Kinetics | 1 | 1990 | 6348 | 0.010 |
Why?
|
| Selenium | 1 | 1985 | 419 | 0.010 |
Why?
|
| Lymphocytosis | 1 | 1983 | 121 | 0.010 |
Why?
|
| Carotenoids | 1 | 1985 | 621 | 0.010 |
Why?
|
| Diplopia | 1 | 1983 | 217 | 0.010 |
Why?
|
| Vincristine | 1 | 1984 | 1039 | 0.010 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1981 | 42 | 0.010 |
Why?
|
| Health Education | 1 | 1988 | 1059 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1985 | 1421 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1982 | 271 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1996 | 916 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1978 | 5192 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1980 | 5952 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1985 | 707 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1990 | 5904 | 0.010 |
Why?
|
| Prednisone | 1 | 1984 | 1568 | 0.010 |
Why?
|
| Syndrome | 1 | 1985 | 3278 | 0.010 |
Why?
|
| Breast Neoplasms | 3 | 1998 | 21156 | 0.010 |
Why?
|
| Leukocytes | 1 | 1985 | 2030 | 0.010 |
Why?
|
| Granuloma | 1 | 1979 | 331 | 0.010 |
Why?
|
| Spleen | 1 | 1983 | 2298 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1989 | 2768 | 0.010 |
Why?
|
| Prognosis | 3 | 1993 | 30028 | 0.010 |
Why?
|
| Monocytes | 1 | 1985 | 2591 | 0.010 |
Why?
|
| Pineal Gland | 1 | 1996 | 158 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1980 | 649 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1996 | 882 | 0.010 |
Why?
|
| Adolescent | 2 | 1993 | 89168 | 0.010 |
Why?
|
| Vaccination | 1 | 1985 | 3434 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2001 | 81834 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1984 | 4572 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1230 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1992 | 26395 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1983 | 2665 | 0.010 |
Why?
|
| Melatonin | 1 | 1996 | 669 | 0.010 |
Why?
|
| Pregnancy | 1 | 1992 | 30179 | 0.010 |
Why?
|
| Leukopenia | 1 | 1990 | 214 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 2087 | 0.010 |
Why?
|
| Age Factors | 3 | 1990 | 18478 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1996 | 2942 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1996 | 4861 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1992 | 1749 | 0.000 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1986 | 58 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6241 | 0.000 |
Why?
|
| Mesocricetus | 1 | 1986 | 255 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1983 | 4906 | 0.000 |
Why?
|
| Mastectomy, Segmental | 1 | 1989 | 961 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1986 | 1154 | 0.000 |
Why?
|
| Liver | 1 | 1979 | 7575 | 0.000 |
Why?
|
| Inflammation | 1 | 1983 | 10865 | 0.000 |
Why?
|
| Hematologic Diseases | 1 | 1987 | 499 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 7599 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1996 | 4533 | 0.000 |
Why?
|
| Periodontal Diseases | 1 | 1984 | 455 | 0.000 |
Why?
|
| Mastectomy | 1 | 1989 | 1852 | 0.000 |
Why?
|
| Postoperative Care | 1 | 1986 | 1481 | 0.000 |
Why?
|
| Patient Participation | 1 | 1989 | 1450 | 0.000 |
Why?
|
| Radiotherapy | 1 | 1986 | 1510 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1978 | 7471 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1984 | 1232 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1985 | 3635 | 0.000 |
Why?
|
| Family | 1 | 1989 | 3208 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1988 | 6320 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1987 | 2102 | 0.000 |
Why?
|
| Rats | 1 | 1991 | 23839 | 0.000 |
Why?
|
| Mice | 2 | 1996 | 82045 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1989 | 41797 | 0.000 |
Why?
|
Concepts
(290)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_